131 related articles for article (PubMed ID: 26903164)
1. [Development of New Molecular EZH2 on Lung Cancer Invasion and Metastasis].
Xia H; Yu C; Zhang W; Zhang B; Zhao Y
Zhongguo Fei Ai Za Zhi; 2016 Feb; 19(2):98-101. PubMed ID: 26903164
[TBL] [Abstract][Full Text] [Related]
2. EZH2 enhances expression of CCL5 to promote recruitment of macrophages and invasion in lung cancer.
Xia L; Zhu X; Zhang L; Xu Y; Chen G; Luo J
Biotechnol Appl Biochem; 2020 Nov; 67(6):1011-1019. PubMed ID: 31855281
[TBL] [Abstract][Full Text] [Related]
3. Loss of long noncoding RNA FOXF1-AS1 regulates epithelial-mesenchymal transition, stemness and metastasis of non-small cell lung cancer cells.
Miao L; Huang Z; Zengli Z; Li H; Chen Q; Yao C; Cai H; Xiao Y; Xia H; Wang Y
Oncotarget; 2016 Oct; 7(42):68339-68349. PubMed ID: 27577075
[TBL] [Abstract][Full Text] [Related]
4. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
[TBL] [Abstract][Full Text] [Related]
5. Long intergenic noncoding RNA 00673 promotes non-small-cell lung cancer metastasis by binding with EZH2 and causing epigenetic silencing of HOXA5.
Ma C; Wu G; Zhu Q; Liu H; Yao Y; Yuan D; Liu Y; Lv T; Song Y
Oncotarget; 2017 May; 8(20):32696-32705. PubMed ID: 28423732
[TBL] [Abstract][Full Text] [Related]
6. The molecular mechanisms and therapeutic potential of EZH2 in breast cancer.
Adibfar S; Elveny M; Kashikova HS; Mikhailova MV; Farhangnia P; Vakili-Samiani S; Tarokhian H; Jadidi-Niaragh F
Life Sci; 2021 Dec; 286():120047. PubMed ID: 34653429
[TBL] [Abstract][Full Text] [Related]
7. The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer.
Li Z; Hou P; Fan D; Dong M; Ma M; Li H; Yao R; Li Y; Wang G; Geng P; Mihretab A; Liu D; Zhang Y; Huang B; Lu J
Cell Death Differ; 2017 Jan; 24(1):59-71. PubMed ID: 27716745
[TBL] [Abstract][Full Text] [Related]
8. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis.
Liu H; Li W; Yu X; Gao F; Duan Z; Ma X; Tan S; Yuan Y; Liu L; Wang J; Zhou X; Yang Y
Oncotarget; 2016 Aug; 7(35):56338-56354. PubMed ID: 27472460
[TBL] [Abstract][Full Text] [Related]
9. The pharmacological and biological importance of EZH2 signaling in lung cancer.
Entezari M; Taheriazam A; Paskeh MDA; Sabouni E; Zandieh MA; Aboutalebi M; Kakavand A; Rezaei S; Hejazi ES; Saebfar H; Salimimoghadam S; Mirzaei S; Hashemi M; Samarghandian S
Biomed Pharmacother; 2023 Apr; 160():114313. PubMed ID: 36738498
[TBL] [Abstract][Full Text] [Related]
10. The NKD1/Rac1 feedback loop regulates the invasion and migration ability of hepatocarcinoma cells.
Li J; Zhang S; Hu Q; Zhang K; Jin J; Zheng X; Yin Z; Wang X
Sci Rep; 2016 May; 6():26971. PubMed ID: 27231134
[TBL] [Abstract][Full Text] [Related]
11. Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B.
Yang F; Lv LZ; Cai QC; Jiang Y
World J Gastroenterol; 2015 Dec; 21(47):13268-76. PubMed ID: 26715809
[TBL] [Abstract][Full Text] [Related]
12. MiR-101-3p Regulates the Viability of Lung Squamous Carcinoma Cells via Targeting EZH2.
Hou Y; Li L; Ju Y; Lu Y; Chang L; Xiang X
J Cell Biochem; 2017 Oct; 118(10):3142-3149. PubMed ID: 27966775
[TBL] [Abstract][Full Text] [Related]
13. EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer.
Han T; Jiao F; Hu H; Yuan C; Wang L; Jin ZL; Song WF; Wang LW
Oncotarget; 2016 Mar; 7(10):11194-207. PubMed ID: 26848980
[TBL] [Abstract][Full Text] [Related]
14. EZH2 promotes invasion and metastasis of laryngeal squamous cells carcinoma via epithelial-mesenchymal transition through H3K27me3.
Luo H; Jiang Y; Ma S; Chang H; Yi C; Cao H; Gao Y; Guo H; Hou J; Yan J; Sheng Y; Ren X
Biochem Biophys Res Commun; 2016 Oct; 479(2):253-259. PubMed ID: 27638307
[TBL] [Abstract][Full Text] [Related]
15. Elevated Metabolic Activity on
Toyokawa G; Takada K; Okamoto T; Kozuma Y; Matsubara T; Haratake N; Akamine T; Takamori S; Katsura M; Shoji F; Hamamoto R; Oda Y; Maehara Y
Anticancer Res; 2017 Mar; 37(3):1393-1401. PubMed ID: 28314309
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of EZH2 via activation of SAPK/JNK and reduction of p65 and DNMT1 as a novel mechanism in inhibition of human lung cancer cells by polyphyllin I.
Li L; Wu J; Zheng F; Tang Q; Wu W; Hann SS
J Exp Clin Cancer Res; 2016 Jul; 35(1):112. PubMed ID: 27421653
[TBL] [Abstract][Full Text] [Related]
18. Role of STAT3 and vitamin D receptor in EZH2-mediated invasion of human colorectal cancer.
Lin YW; Ren LL; Xiong H; Du W; Yu YN; Sun TT; Weng YR; Wang ZH; Wang JL; Wang YC; Cui Y; Sun DF; Han ZG; Shen N; Zou W; Xu J; Chen HY; Cao W; Hong J; Fang JY
J Pathol; 2013 Jul; 230(3):277-90. PubMed ID: 23424038
[TBL] [Abstract][Full Text] [Related]
19. Enhancer of zeste homolog 2 expression is associated with tumor cell proliferation and invasion in cervical cancer.
Fang J; Zhang M; Li Q
Am J Med Sci; 2011 Sep; 342(3):198-204. PubMed ID: 21629038
[TBL] [Abstract][Full Text] [Related]
20. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
